Anavex Life Sciences Corp (AVXL)

[stealthways]

thinking they would have to have been prepared for the worst case situation --- i.e. that NAS rejected this cat $3.00 app and moved them to the $4 category .... and with the volatility of Bios, coupled with recent short attacks they would have had to target at least $5, with any kind of cushion ....especially knowing the cost of the uplisting is expensive and failure here would not be good.....